These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 22496030)
1. Intravitreal administration of ranibizumab for idiopathic choroidal neovascularization in a pregnant woman. Sarhianaki A; Katsimpris A; Petropoulos IK; Livieratou A; Theoulakis PE; Katsimpris JM Klin Monbl Augenheilkd; 2012 Apr; 229(4):451-3. PubMed ID: 22496030 [No Abstract] [Full Text] [Related]
2. Intravitreal ranibizumab injection for choroidal neovascularization in Strümpell-Lorrain Syndrome. Tran TH; Baglin G; Querques G J Fr Ophtalmol; 2012 May; 35(5):353-5. PubMed ID: 22463854 [TBL] [Abstract][Full Text] [Related]
3. Retinal pigment epithelium tear formation following intravitreal ranibizumab injection in choroidal neovascularization secondary to choroidal osteoma. Erol MK; Coban DT; Ceran BB; Bulut M Cutan Ocul Toxicol; 2014 Sep; 33(3):259-63. PubMed ID: 24517498 [TBL] [Abstract][Full Text] [Related]
4. Management of inflammatory choroidal neovascularization (CNV) secondary to punctate inner choroidopathy in a young female of childbearing age with intra-vitreal ranibizumab and half-fluence photodynamic therapy (PDT) - a holistic approach. Cornish KS; Lim LT; Imrie F Semin Ophthalmol; 2012; 27(1-2):29-32. PubMed ID: 22352824 [TBL] [Abstract][Full Text] [Related]
5. Combined fluorescein angiography and spectral-domain optical coherence tomography imaging of classic choroidal neovascularization secondary to age-related macular degeneration before and after intravitreal ranibizumab injections. Coscas F; Querques G; Forte R; Terrada C; Coscas G; Souied EH Retina; 2012 Jun; 32(6):1069-76. PubMed ID: 22466476 [TBL] [Abstract][Full Text] [Related]
6. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization. Rouvas A; Petrou P; Douvali M; Ntouraki A; Vergados I; Georgalas I; Markomichelakis N Retina; 2011 May; 31(5):871-9. PubMed ID: 21358461 [TBL] [Abstract][Full Text] [Related]
7. Circumscribed choroidal hemangioma associated with choroidal neovascularization in a HIV-infected case: photodynamic therapy and intravitreous ranibizumab. Hua R; Zhao N; Hu Y; Zhang CM; Chen L Photodiagnosis Photodyn Ther; 2014 Sep; 11(3):441-3. PubMed ID: 24784430 [TBL] [Abstract][Full Text] [Related]
11. Reduction of vascular endothelial growth factor a in human breast milk after intravitreal injection of bevacizumab but not ranibizumab. Ehlken C; Martin G; Stahl A; Agostini HT Arch Ophthalmol; 2012 Sep; 130(9):1226-7. PubMed ID: 22965611 [No Abstract] [Full Text] [Related]
12. Positive response to intravitreal ranibizumab in the treatment of choroidal neovascularization secondary to punctate inner choroidopathy. Menezo V; Cuthbertson F; Downes SM Retina; 2010 Oct; 30(9):1400-4. PubMed ID: 20224465 [TBL] [Abstract][Full Text] [Related]
13. Predictive factors of resolved retinal fluid after intravitreal ranibizumab for polypoidal choroidal vasculopathy. Koizumi H; Yamagishi T; Yamazaki T; Kinoshita S Br J Ophthalmol; 2011 Nov; 95(11):1555-9. PubMed ID: 21890787 [TBL] [Abstract][Full Text] [Related]
14. Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to endogenous endophthalmitis. Sheu SJ Kaohsiung J Med Sci; 2009 Nov; 25(11):617-21. PubMed ID: 19858042 [TBL] [Abstract][Full Text] [Related]
15. Combination treatment with intravitreal injection of ranibizumab and reduced fluence photodynamic therapy for choroidal neovascularization secondary to angioid streaks: preliminary clinical results of 12-month follow-up. Artunay O; Yuzbasioglu E; Rasier R; Sengul A; Senel A; Bahcecioglu H Retina; 2011; 31(7):1279-86. PubMed ID: 21394063 [TBL] [Abstract][Full Text] [Related]
16. [Patient with type II membranoproliferative glomerulonephritis: intravitreal bevacizumab therapy for choroidal neovascularization]. Karampelas M; Kopsachilis N; Chang JH; Pal B Ophthalmologe; 2012 Aug; 109(8):791-3. PubMed ID: 22911355 [TBL] [Abstract][Full Text] [Related]
17. Intravitreal ranibizumab for choroidal neovascularization secondary to pathologic myopia: 12-month results. Monés JM; Amselem L; Serrano A; Garcia M; Hijano M Eye (Lond); 2009 Jun; 23(6):1275-80; quiz 1281. PubMed ID: 19478826 [TBL] [Abstract][Full Text] [Related]
18. Fibrosis of extramacular angioid streaks following ranibizumab treatment of subfoveal choroidal neovascularization. Bloch SB; Larsen M Acta Ophthalmol; 2011 Feb; 89(1):e102-4. PubMed ID: 20222906 [No Abstract] [Full Text] [Related]
19. Ranibizumab for choroidal neovascularization secondary to causes other than age-related macular degeneration: a phase I clinical trial. Heier JS; Brown D; Ciulla T; Abraham P; Bankert JM; Chong S; Daniel PE; Kim IK Ophthalmology; 2011 Jan; 118(1):111-8. PubMed ID: 20678799 [TBL] [Abstract][Full Text] [Related]
20. Inadvertent use of bevacizumab to treat choroidal neovascularisation during pregnancy: a case report. Wu Z; Huang J; Sadda S Ann Acad Med Singap; 2010 Feb; 39(2):143-5. PubMed ID: 20237737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]